Targeted drugs that attack the genetic machinery of cancer with laser-like precision are, in a select group of patients, melting tumors away, often with few side effects. The problem is, almost invariably, these medications eventually stop working. … “It’s so much in our thinking today. As soon as we have an effective drug, we start thinking, ‘How does the drug begin to lose its benefit?” said Dr. Pasi Janne, an oncologist at Dana-Farber Cancer Institute. “This is really rising to the forefront.”
http://www.boston.com/lifestyle/health/articles/2011/11/21/successes_in_fighting_cancer_bring_new_challenge_drug_resistance/
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?